MedTrace Logo

Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine

NCT02981030 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2018-06-18

No results posted yet for this study

Summary

The study will examine how a simplified outpatient medical abortion procedure using mifepristone and misoprostol, with the option to take mifepristone at a place of woman's choosing, works in Ukraine. The investigators intend to demonstrate the efficacy of oral administration of 200 mg mifepristone and buccal administration of 800 mcg misoprostol with gestations through 70 days, as well as the acceptability of this method.

Conditions

  • Abortion, Therapeutic

Interventions

DRUG

Mifepristone

Women seeking medical abortion will be offered the option to take mifepristone at home

DRUG

Misoprostol

Women seeking medical abortion will be offered the option to take misoprostol at home. Misoprostol will be administered buccally.

Sponsors & Collaborators

  • Charitable Foundation Women Health & Family Planning

    collaborator UNKNOWN

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Ingrida Platais, MS · Gynuity Health Projects

  • Tamar Tsereteli, MD, MSc, PhD · Gynuity Health Projects

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

  • Galyna Maystruk, MD · Charitable Foundation Women Health & Family Planning

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-23
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Ukraine

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02981030 on ClinicalTrials.gov